Telomir Pharmaceuticals Management
Management criteria checks 0/4
Telomir Pharmaceuticals' CEO is Erez Aminov, appointed in Aug 2024, has a tenure of less than a year. directly owns 0.1% of the company’s shares, worth $134.70K. The average tenure of the management team and the board of directors is 0.3 years and 0.3 years respectively.
Key information
Erez Aminov
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.1% |
| Management average tenure | less than a year |
| Board average tenure | less than a year |
Recent management updates
CEO
Erez Aminov (46 yo)
less than a year
Tenure
Mr. Erez Aminov is Chairman of the Board and Chief Executive Officer at Telomir Pharmaceuticals, Inc. since August 2024. He is Chief Executive Officer of MIRA Pharmaceuticals, Inc. from April 28, 2023 and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | less than a year | no data | 0.10% $ 134.7k | |
| Co-founder | no data | no data | 7.16% $ 9.5m | |
| Chief Financial Officer | less than a year | no data | 0.082% $ 109.5k | |
| Chief Scientific Advisor | less than a year | no data | no data |
0.3yrs
Average Tenure
Experienced Management: TELO's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | less than a year | no data | 0.10% $ 134.7k | |
| Independent Director | 2yrs | no data | 1.65% $ 2.2m | |
| Independent Director | less than a year | no data | no data | |
| Director | less than a year | no data | no data | |
| Director | less than a year | no data | no data | |
| Director | less than a year | no data | no data |
0.3yrs
Average Tenure
42yo
Average Age
Experienced Board: TELO's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.